Until that comes about, however, companies in the industry must look elsewhere for revenues. Yong Shin, for example, derived 10 % of its operating revenues last year (NT $ 300 million) from health foods and over-the-counter drugs. Another go at biotech
但在此之前，大夥只能另尋財源，譬如永信去年 10 % 的營收（台幣 3 億元），便是來自保健食品，以及不需經過醫師處方即可在藥師建議下自行購買的指示用藥（簡稱 OTC）。